KOL Breakfast on Peripheral Artery Disease (PAD)
KOL Breakfast on Peripheral Artery Disease (PAD)

Webcast Information

QA Information



INSPIRED by LIFE

Pluristem Therapeutics Inc.’s cell therapy products are designed to treat patients by stimulating their bodies’ own regenerative mechanisms

  • Clinical Programs

  • Products

  • Science & Technology

  • Benefits

    Technology platform for cell products, targeting treatment for a range of indications

  • Cell profiling expertise

    Deep understanding of the cell secretion profiles that generate therapeutic effects

  • Manufacturing facility

    Company-owned and operated GMP-certified manufacturing and research facilities

News

  • 04/12/2018Pluristem Therapeutics Enters into Cell Thawing Device License Agreement with Chart Industries, Inc.

    Read More